Danazol

• 

  Subject Areas on Research

  • Acquired C1-inhibitor deficiency. 
  • Acquired hypoprothrombinemia: effects of danazol treatment. 
  • Acute upper airway angioedema secondary to acquired C1 esterase inhibitor deficiency: a case report. 
  • An overview of novel therapies for acute hereditary angioedema. 
  • Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease. 
  • Danazol-induced cystitis: an undescribed source of hematuria in patients with hereditary angioneurotic edema. 
  • Danazol-induced elevation of serum alpha 1-antitrypsin in individuals with severe deficiency of this antiprotease. 
  • Danazol: an antigonadotropic agent in the treatment of pelvic endometriosis. 
  • Danazole in the treatment of hereditary angioedema. 
  • Effect of sex hormones on the complement-related clinical disorder of hereditary angioedema. 
  • Evaluation of danazol as an oral contraceptive. 
  • Hereditary angioedema: the rewards of studying a rare disease. 
  • How I treat thrombocytopenia in pregnancy. 
  • Long-term therapy of hereditary angioedema with danazol. 
  • Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency. 
  • Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP). 
  • Response of variant hereditary angioedema phenotypes to danazol therapy. Genetic implications. 
  • The C1 esterase inhibitor and hereditary angioedema. 
  • The effect of danazol in the treatment of chronic cystic mastitis. 
  • The long-term safety of danazol in women with hereditary angioedema. 
  • Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. 
  • Update on preventive therapy (prophylaxis) of hereditary angioedema.